These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9028964)

  • 1. Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia.
    Inoue K; Ogawa H; Sonoda Y; Kimura T; Sakabe H; Oka Y; Miyake S; Tamaki H; Oji Y; Yamagami T; Tatekawa T; Soma T; Kishimoto T; Sugiyama H
    Blood; 1997 Feb; 89(4):1405-12. PubMed ID: 9028964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells.
    Hosen N; Sonoda Y; Oji Y; Kimura T; Minamiguchi H; Tamaki H; Kawakami M; Asada M; Kanato K; Motomura M; Murakami M; Fujioka T; Masuda T; Kim EH; Tsuboi A; Oka Y; Soma T; Ogawa H; Sugiyama H
    Br J Haematol; 2002 Feb; 116(2):409-20. PubMed ID: 11841446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
    Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
    Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotypic and functional characterization of CD33(+)CD34(+) cells in human cord blood of preterm neonates.
    Jin CH; Takada H; Nomura A; Takahata Y; Nakayama H; Kajiwara M; Nakano H; Hara T
    Exp Hematol; 2000 Oct; 28(10):1174-80. PubMed ID: 11027836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Elimination of leukemic CD34+ progenitor cells by using cytotoxic T lymphocytes specifically targeting WT1-derived peptide: an experimental study in vitro].
    Gu WY; Chen ZX; Qiu GQ; Hu SY; Jia L; Wu W; He J; Cen JN; He B
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3401-6. PubMed ID: 19159569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.
    Rappold I; Ziegler BL; Köhler I; Marchetto S; Rosnet O; Birnbaum D; Simmons PJ; Zannettino AC; Hill B; Neu S; Knapp W; Alitalo R; Alitalo K; Ullrich A; Kanz L; Bühring HJ
    Blood; 1997 Jul; 90(1):111-25. PubMed ID: 9207445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface antigen expression on CD34+ cord blood cells: comparative analysis by flow cytometry and limiting dilution (LD) RT-PCR of chymopapain-treated or untreated cells.
    Ziegler BL; Thoma SJ; Lamping CP; Valtieri M; Müller R; Samoggia P; Bühring HJ; Peschle C; Fliedner TM
    Cytometry; 1996 Sep; 25(1):46-57. PubMed ID: 8875054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis.
    Baird PN; Simmons PJ
    Exp Hematol; 1997 Apr; 25(4):312-20. PubMed ID: 9131006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The "common stem cell" hypothesis reevaluated: human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors.
    Waller EK; Olweus J; Lund-Johansen F; Huang S; Nguyen M; Guo GR; Terstappen L
    Blood; 1995 May; 85(9):2422-35. PubMed ID: 7537114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of the Wilms tumor gene (WT1) at relapse in acute leukemia.
    Tamaki H; Ogawa H; Inoue K; Soma T; Yamagami T; Miyake S; Oka Y; Oji Y; Tatekawa T; Tsuboi A; Tagawa S; Kitani T; Aozasa K; Kishimoto T; Sugiyama H; Miwa H; Kita K
    Blood; 1996 Dec; 88(11):4396-8. PubMed ID: 8943879
    [No Abstract]   [Full Text] [Related]  

  • 11. CD34(+)/CD38(-) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin.
    Herrmann H; Cerny-Reiterer S; Gleixner KV; Blatt K; Herndlhofer S; Rabitsch W; Jäger E; Mitterbauer-Hohendanner G; Streubel B; Selzer E; Schwarzinger I; Sperr WR; Valent P
    Haematologica; 2012 Feb; 97(2):219-26. PubMed ID: 21993666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of MDR1 by normal bone marrow cells and its implication for leukemic hematopoiesis.
    Drach J; Zhao S; Drach D; Körbling M; Engel H; Andreeff M
    Leuk Lymphoma; 1995 Feb; 16(5-6):419-24. PubMed ID: 7540457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis.
    Hosen N; Shirakata T; Nishida S; Yanagihara M; Tsuboi A; Kawakami M; Oji Y; Oka Y; Okabe M; Tan B; Sugiyama H; Weissman IL
    Leukemia; 2007 Aug; 21(8):1783-91. PubMed ID: 17525726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment.
    Gattei V; Celetti A; Cerrato A; Degan M; De Iuliis A; Rossi FM; Chiappetta G; Consales C; Improta S; Zagonel V; Aldinucci D; Agosti V; Santoro M; Vecchio G; Pinto A; Grieco M
    Blood; 1997 Apr; 89(8):2925-37. PubMed ID: 9108413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [WT1 gene expression and its isoform ratio in different cell subsets of normal human bone marrow].
    Xu J; Wang HW; Li XH; Zhu L; Zhang L; Zhang F; Tan YH; Yang T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):603-6. PubMed ID: 17605875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
    Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R
    Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117).
    Blair A; Sutherland HJ
    Exp Hematol; 2000 Jun; 28(6):660-71. PubMed ID: 10880752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.
    Verfaillie CM; Miller JS
    Blood; 1994 Sep; 84(5):1442-9. PubMed ID: 7520771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid-lymphoid initiating cells (ML-IC) are highly enriched in the rhodamine-c-kit(+)CD33(-)CD38(-) fraction of umbilical cord CD34(+) cells.
    Liu H; Verfaillie CM
    Exp Hematol; 2002 Jun; 30(6):582-9. PubMed ID: 12063025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol.
    Gaiger A; Linnerth B; Mann G; Schmid D; Heinze G; Tisljar K; Haas OA; Gadner H; Lion T
    Eur J Haematol; 1999 Aug; 63(2):86-93. PubMed ID: 10480287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.